John Tabuti Robert Stephen
ID: UNCST-2024-R002181
|
Agroforestry for People, Ecosystems and Climate (AfPEC)
REFNo: NS818ES
AfPEC aims to document the effects of agroforestry in terms of ecosystem services and livelihood benefits, to understand motivating factors for long-term sustainable development and to support science-based agroforestry in practice.
|
Uganda |
2024-11-22 17:26:03 |
2027-11-22 |
Natural Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Jennifer Serwanga
ID: UNCST-2024-R002056
|
mAb Therapeutics for Sudan ebolavirus: Discovery, Isolation, and Target-Epitope Mapping of Monoclonal Antibodies from Sudan ebolavirus Convalescent Survivors in Uganda (mATSu)
REFNo: HS5212ES
This study aims to improve understanding and enhance the development of potent immune-based tools for detection, treatment, and vaccination strategies, strengthening readiness for future Viral Hemorrhagic Fever (VHF) epidemics. It will address five specific objectives:
Objective 1: Collect, process and screen samples from Viral Hemorrhagic Fever (VHF) survivor acute and convalescent cases along with their close contacts.
Objective 2: Isolate and characterise functionalities of the monoclonal antibodies.
Objective 3: Establish partnerships to facilitate transfer advanced technologies.
Objective 4: Build local capacity for immune therapies.
Objective 5: Describe molecular determinants underpinning the presence or lack of potent mAbs.
|
Uganda |
2024-11-22 17:23:36 |
2027-11-22 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Pontiano Kaleebu
ID: UNCST-2021-R013577
|
Open-label, Multicenter Immunogenicity and Safety Trial of MVA-BN® Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections
REFNo: HS5281ES
To assess immunogenicity of the MVA-BN standard regimen in eliciting neutralizing antibodies against vaccinia virus in children compared to adults.
To assess the safety and reactogenicity of the MVA-BN standard regimen in children and adults.
To assess neutralizing antibody response to the MVA-BN standard regimen.
To assess durability of neutralizing antibody response to the MVA-BN standard regimen.
|
Uganda |
2024-11-22 17:19:29 |
2027-11-22 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Florence Ebila
ID: UNCST-2021-R013444
|
TASO-2024-401 Beyond Gendered textbooks: An investigation into gender(ed) discourses in secondary English language classrooms in India and Uganda.
REFNo: SS3317ES
3.To analyse the extent to which engaging teachers with gendered classroom practices and learners’ gendered experiences shape their reflections the development of gender responsive pedagogies.,2. To assess how the gendered discourses in the EL classroom influence male and female students’ learning. experiences, self-perception and aspirations,1. To find out how teachers and students engage with gendered texts in the EL classroom.,The aim of this study is to investigate how gender is (co-)constructed in secondary school English language (EL) classrooms in India and Uganda with the view of identifying patterns which would inform gender responsive English language teaching and teacher education.,
|
Uganda |
2024-11-19 7:35:59 |
2027-11-19 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Andrew Mujugira
ID: UNCST-2019-R000871
|
Needs and Experiences of Transgender Women Using Gender-Affirming
Hormone Therapy in Uganda: A Mixed Methods Study
REFNo: HS5137ES
Aim 1: Assessment of needs and experiences to determine gaps in access to gender-affirming treatment in Uganda
Aim 2: Use photovoice methods to gain a better understanding of the real-world healthcare experiences of trans women in Uganda
|
Uganda |
2024-11-19 7:34:06 |
2027-11-19 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|